https://www.thebodypro.com/slideshow/this-week-in-hiv-research-how-low-an-atripla-dose-can-you-go
Efavirenz/Emtricitabine/Tenofovir Disoproxil Fumarate (Atripla)News

This Week in HIV Research: How Low (an Atripla Dose) Can You Go?

VIEW AS: LIST | SLIDES
woman doing limbo under rope
franckreporter via iStock

National Institute of Allergy and Infectious Diseases

Less-Than-Daily Dosing of Atripla Effective in Virally Suppressed People


stethoscope on blank prescription form 300x300
Credit: Andre Blais for iStock via Thinkstock

Among Medically Complex Patients, Few HIV Prescriptions Filled Promptly After Hospital Discharge


Bar graph
nixki for iStock via Thinkstock

U.S. Meets Some, But Not All, UNAIDS Metrics for Ending AIDS by 2030


HCV Revolution

Hepatitis C Was Mostly Transmitted Within Clusters During Outbreak in Lyon, France


Barbara Jungwirth

Barbara Jungwirth

@bjungwirthNY

Barbara Jungwirth is an experienced freelance journalist, writer, and translator who has been reporting on HIV for TheBody and TheBodyPro since 2002.

Myles Helfand

Myles Helfand

@MylesatTheBody

Myles Helfand is the executive editor and general manager of TheBody/TheBodyPro.